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Catecholamines, including dopamine and norepi-
nephrine, are the principal neurotransmitters that
mediate a variety of the central nervous system
functions, such as motor control, cognition, emotion,
memory processing, and endocrine modulation.
Dysfunctions in catecholamine neurotransmission
are implicated in some neurologic and neuropsychia-
tric disorders. Recent mouse molecular genetic
approaches provide genetic evidence for an important
role of catecholamines in brain functions. In this
paper, I describe the phenotype of mutant mice with
impairments in dopamine or norepinephrine bio-
synthesis. Mice defective in dopamine biosynthesis
exhibit severe motor dysfunctions characterized by a
reduction in spontaneous locomotion and cataleptic
behavior, and defects in drug-induced hyperactivity
at the juvenile stage. They also exhibit defects in the
acquisition of conditioned learning dependent on
tone stimulus. These results indicate that dopamine is
essential for motor control and emotional learning
during postnatal development, possibly through
nigrostriatal and mesolimbic neuronal pathways. On
the other hand, mice carrying the mutation in the
gene encoding tyrosine hydroxylase (the rate-limiting
enzyme of catecholamine biosynthesis) display a
reduction in norepinephrine biosynthesis. This leads
to de®cits in latent learning and long-term memory
formation of different conditioned learning para-
digms. The results indicate that norepinephrine is
essential for the consolidation process of long-term
memory, suggesting that norepinephrine may control
the neuronal activity in the cerebral cortex or amyg-
dala to maintain the memory process of conditioned
learning. Key words: gene targeting/long-term memory/
motor control/tyrosine hydroxylase. Journal of Investigative
Dermatology Symposium Proceedings 6:115±121, 2001
C
atecholamines, including dopamine and norepi-
nephrine, are the principal neurotransmitters that
mediate a variety of the central nervous system
(CNS) functions, such as motor control, cognition,
emotion, memory processing, and endocrine
regulation. The cell groups producing catecholamines are
localized in discrete brain regions and project their axon
terminals to a wide range of target areas that play an important
role in the CNS functions. At the cellular level, catecholaimes
modulate the activity of target neurons by opening or closing
ion channels depending on the receptor subtypes involved
(Nicoll et al, 1990). Dysfunction in catecholamine systems is
implicated in the onset and pathologic state of several
neurologic and neuropsychiatric disorders (Nagatsu et al, 1984;
Rubin et al, 1985; Davidson et al, 1987; Oades, 1987).
The major dopaminergic cell groups are localized in the
ventral region of the midbrain, including the substantia nigra
(A9 cell group) and ventral tegmental area (A10 cell group)
(Lindvall and BjoÈklund, 1983). The A9 neurons project their
massive ®bers to the caudate-putamen to form the nigrostriatal
pathway, which plays a central role in motor control (Gerfen,
1992). The A10 neurons innervate the nucleus accumbens,
amygdala, and prefrontal cortex to form the mesocorticolimbic
pathway. This pathway is involved in emotion, motivation, and
memory formation (Le Moal and Simon, 1991). There are
other dopaminergic cell groups (A11±A14) in the mediobasal
region of the hypothalamus innervating the median eminence
and pituitary gland (Moore and Lookingland, 1995). The
hypothalamic dopaminergic neurons modulate development
and maintenance of the pituitary gland as well as gene
expression and metabolism of pituitary peptide hormones.
The central norepinephrine system originates from certain cell
groups in the locus coeruleus (A6 cell group) and the lateral
tegmental area in the brain stem (A1, A2, A5, and A7 cell
groups) (Moore and Card, 1984). The A6 neurons project to
the cerebral cortex, amygdala, hippocampus, and thalamus
through the dorsal norepinephrinergic pathway. Other central
norepinephrinergic neurons comprise the ventral norepinephri-
nergic pathway, and innervate mainly the septum and
hypothalamus. The central norepinephrinergic neurons are
known to be implicated in cognitive functions, including
attention and memory formation, as well as vegetative functions,
including neuroendocrine and autonomic regulation (Robbins
and Everitt, 1995). The dorsal and ventral pathways appear to
play the relative roles in cognitive and vegetative functions,
respectively (Selden et al, 1993).
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A number of pharmacologic and behavioral approaches have
been applied to elucidate brain functions mediated by catechola-
mines; however, little is known about molecular and cellular
mechanisms underlying catecholaminergic control of these brain
functions. For a clearer understanding of this issue, it is useful to
have mutant mice possessing alterations in gene function involved
in catecholaime biosynthesis, metabolism, and neurotransmission.
In this paper, I describe the mutant phenotype of mice genetically
impaired in dopamine or norepinephrine biosynthesis, and show
genetic evidence for the behavioral and physiologic role of these
two catecholamines in the CNS functions.
IMPAIRMENT OF DOPAMINE BIOSYNTHESIS
The gene encoding tyrosine hydroxylase (TH), which is the initial
and rate-limiting enzyme of the catecholamine biosynthetic
pathway, was initially disrupted by gene targeting (Kobayashi et
al, 1995). The knockout mutation of the TH gene resulted in
severe depletion of dopamine and norepinephrine, which led to the
lethality at the prenatal and neonatal stages apparently because of
cardiovascular failure. To generate mutant mice defective in
dopamine biosynthesis, the transgenic rescue approach was utilized
(Nishii et al, 1998). In this approach, the expression of TH in
Figure 1. Impairment of motor control and emotional learning in dopamine-de®cient mice. (A) Appearance of a dopamine-de®cient mutant
mouse (3 wk old). The mutant mouse exhibits growth retardation until this stage. (B) Spontaneous locomotor activity of 3-wk-old mice. Locomotion
activity (upper panel) and rearing activity (lower panel), de®ned as the total number of beam breaks by horizontal and vertical movements, respectively, of
the wild-type mice and mutant mice are shown. Values represent mean 6 SE of the data. Open columns, wild-type mice (n = 13); closed columns,
mutant mice (n = 12). The asterisks indicate a signi®cant difference (*p < 0.01) from the wild-type value (Student's t test). (C) Photograph of a
dopamine-de®cient mouse during the parallel bar test. In this test, mice were forced to take a bizarre posture setting forepaws on the bar and hindpaws
on the ¯oor. (D) Cataleptic behavior scored by the parallel bar test. Mice were categorized into four groups (< 1 s, 1±10 s, 10±30 s, and > 30 s)
depending on the time taking a bizarre posture during the test. The percentage of the number of animals in each group is indicated (wild-type mice, n
= 26; mutant mice, n = 21). (E) Methamphetamine-induced hyperactivity. Mice (3 wk old) were treated with methamphetamine (3 mg per kg, s.c.)
or saline, then locomotor activity was monitored for 20 min. Hyperactivity is evaluated as the relative ratio of the locomotor activity after treatment to
the basal activity. Values are mean 6 SE for methamphetamine injection (n = 6) and saline injection (n = 5). Open columns, wild-type mice; closed
columns, mutant mice. MAP, methamphetamine. ANOVA indicated a signi®cant interaction genotype and treatment factors [F (1, 10) = 11.93, p
< 0.01]. In the wild-type mice, there was a signi®cant difference between methamphetamine and saline treatment (*p < 0.05), but in the mutant mice
the difference was not signi®cant (NS) between the two kinds of treatment. The methamphetamine-induced hyperactivity in the mutant mice was
signi®cantly lower than that in the wild-type mice (²p < 0.05). (F) Emotional learning evaluated by active avoidance task. Mice (3 wk old) were tested
for the acquisition of active avoidance response triggered by a tone stimulus. The shuttle box apparatus consisted of two compartments with a grid ¯oor
including one light and one dark chamber. The mice were given 5 s of a tone stimulus in the dark compartment. Then an electric shock (0.2 mA, 5 s)
was delivered to the feet with a scrambled shock generator. When the mouse moved into the light compartment before the onset of the footshock,
such action was counted as an avoidance. Each animal was given 10 trials per day for seven consecutive days. Percentage of successful avoidances in 10
trials per day is plotted. Values indicate mean 6 SE of the data. Open circles, wild-type mice (n = 10); closed circles, mutant mice (n = 6). ANOVA
indicated signi®cant main effects of genotypes [F (1, 14) = 13.77, p < 0.01] and trial days [F (6, 84) = 22.04, p < 0.01].
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norepinephrinergic neurons in the TH mutant mice was rescued
with the dopamine b-hydroxylase gene promoter, which is
functional in norepinephrinergic cell types. This resulted in a
deletion of TH expression in the neuronal types that normally
synthesize dopamine. In these mice, dopamine accumulation
showed a remarkable reduction in the forebrain (2.3%), midbrain
(11%), hindbrain (40%), and pituitary gland (36%) of the wild-type
values, whereas norepinephrine accumulation was restored to the
normal levels.
Dopamine-de®cient mice grew normally up to around 10 d after
birth, but at postnatal day 10±14 (P10±14) they were distinguish-
able from other littermates owing to their small size. During
subsequent development, they lost more body weight and gradually
weakened (see Fig 1A). Finally, all of them died by P30. The brain
weight of the mutant mouse was reduced to 87% of the wild-type
mouse weight at P21, but the gross morphology of the mutant
brain appeared to be normal. The phenotypic abnormalities of the
mutant mice revealed that dopamine is essential for animal
development and survival during the juvenile stage.
Dopamine-de®cient mice exhibited impairment in motor con-
trol functions during the juvenile stage past P14. First, the
spontaneous locomotor activity of the mutant mice displayed a
Figure 2. Compensation of pituitary development and hormone metabolism in dopamine-de®cient mice. (A) Histology of pituitary glands.
Pituitary sections of 3-wk-old mice stained with hematoxylin and eosin (HE), and immunohistochemistry using anti-prolactine (PRL) or anti-a-
melanocyte-stimulatory hormone (a-MSH)) antibody. AL, anterior lobe; IL, intermediate lobe; PL, posterior lobe. Scale bars: 100 mm (HE staining),
200 mm (PRL and a-MSH staining). (B) Serum PRL and a-MSH levels. Radioimmunoassay of pituitary hormone contents in the serum samples
collected from 3-wk-old mice. Values indicate mean 6 SE of the data. Serum PRL level: wild-type mice (n = 9), mutant mice (n = 6); serum a-
MSH level: wild-type mice (n = 6), mutant mice (n = 5). The difference in the PRL or a-MSH levels between the two groups of mice was not
statistically signi®cant (Student's t test).
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signi®cant reduction relative to the wild-type mice; the horizontal
and vertical movements were decreased to about 43% and 30% of
the controls, respectively (Fig 1B). Second, the mutant mice
exhibited the cataleptic behavior, which is de®ned as the absence of
voluntary movement. When the mice were assayed by the parallel
bar test, the mutant mice maintained a bizarre posture on the bar
much longer than the wild-type mice (Fig 1C, D). Third, the
mutant was insensitive to the methamphetamine treatment, which
normally induces the hyperactivity of locomotion (Fig 1E).
Normally, these motor control functions are mediated by the
nigrostriatal or mesocorticolimbic dopaminergic pathway (Lindvall
and BjoÈklund, 1983). The two pathways are assumed to participate
in a neuronal network loop for modulating spontaneous and drug-
induced locomotor activity. In contrast, it appears that the primary
site of cataleptogenesis by dopamine receptor blockers is the
caudate-putamen, the terminal region of the nigrostriatal pathway
(Dunstan et al, 1980). The abnormalities of motor responses in
dopamine-de®cient mice are considered to result from a combined
loss of the actions through the two major dopaminergic pathways.
In addition to the motor dysfunctions, dopamine-de®cient mice
displayed defects in a certain emotional learning paradigm. Active
avoidance is the paradigm that monitors the performance to escape
an aversive unconditioned stimulus of footshock (US) paired with a
conditioned stimulus of tone (CS). The task requires an association
between an US and a CS. The mutant mice learned the active
avoidance task much more slowly than the wild-type mice
(Fig 1F). In the ®nal session of the training, the success of
avoidance in the mutant mice was only 60%. There was no
difference in the escape latency, which de®nes the time taken
between onset of the footshock and initiation of the response, and
in the pain sensitivity between the wild-type and the mutant mice,
suggesting that the mutant mice normally initiated movement in
response to the footshock. Thus, the impairment in the active
avoidance may be attributable to de®cits in the learning perform-
ance. The previous study with a different active avoidance task
using the lever press paradigm suggests that the avoidance response
is disrupted by dopamine depletion in nucleus accumbens
(McCullough et al, 1993). The abnormalities of emotional learning
in dopamine-de®cient mice could be explained predominantly by
the de®cits in the mesolimbic dopaminergic pathway projecting to
the nucleus accumbens.
The behavioral abnormalities of the mutant mice demonstrate
that dopamine plays an essential role in movement control and
emotional learning during postnatal development, possibly through
the nigrostriatal and mesocorticolimbic pathways. The dopaminer-
gic cell groups become organized into a pattern similar to that seen
in adult animals during the ®rst postnatal week (Kalsbeek et al,
1992). Also, TH activity and dopamine level in the brain show a
progressive increase after birth until the third postnatal week
(Giorgi et al, 1987; Kalaria and Prince, 1988). The onset of the
behavioral abnormalities agrees well with the period when the
developmental changes in dopaminergic neurons proceed.
Additionally, the dopaminergic pathway from the hypothalamus
is known to negatively regulate cell proliferation and maintenance
of the pituitary gland (Bevan et al, 1992; Gary and Chronwall,
1992) as well as its neuroendocrine functions (Beaulieu et al, 1984;
Ben-Jonathan et al, 1989); however, dopamine-de®cient mice
never displayed remarkable changes in gross morphology of the
pituitary gland, cell density of the lactotroph and melanotroph
(Fig 2A), and serum levels of prolactin and a-melanocyte stimu-
lating hormone (Fig 2B). These results suggest the presence of
compensatory mechanisms in the pituitary for dopamine depletion.
One of the possible mechanisms is an upregulation of dopamine
receptors in response to the decreased dopamine level (Neve et al,
1985; Martres et al, 1992). Another compensatory mechanism may
be the involvement of various factors that activate pituitary
functions, including estrogen (Ellias and Weiner, 1987), thyro-
tropin-releasing factor (Ben-Jonathan et al, 1989), and cortico-
tropin-releasing factor (Proulx-Ferland et al, 1982).
IMPAIRMENT OF NOREPINEPHRINE BIOSYNTHESIS
Mice heterozygous for the mutation in the TH locus show a
reduced TH enzyme activity in the tissues, although they are
apparently normal in development and gross behavior (Kobayashi et
al, 1995). As it is thought that the regulatory mechanism of TH
activity is closely linked to catecholaminergic neuronal activity, the
behavioral and neuropsychologic functions in TH+/± heterozygous
mutant mice have been examined focusing on the norepinephrine
system (Kobayashi et al, 2000). In the heterozygous mutant,
norepinephrine metabolism in the brain was actually reduced as a
consequence of the decreased TH activity. The norepinephrine
level in various brain regions of the mutant mice showed a
Figure 3. Impairment of latent learning in the mice heterozygous
for the TH mutation. (A) Water-®nding test. Nonwater-deprived
animals were placed in an open ®eld apparatus containing a water tube
during a training phase. Then the animals were water-deprived for 1 d
and placed back into the same apparatus. Entering, ®nding, and drinking
latencies of the trained and nontrained mice were measured. Values
represent mean 6 SEM of data. Two-way ANOVA showed a signi®cant
interaction between genotype and training for ®nding latency [F (1,
38) = 4.662, p < 0.05] and for drinking latency [F (1, 38) = 5.827, p
< 0.05]. Signi®cant differences according to Newman-Keuls test: *p
< 0.05 vs nontrained wild-type mice; **p < 0.01 vs nontrained wild-type
mice; and ²p < 0.05 vs trained wild-type mice. (B) Recovery from the
learning defects by desipramine treatment. Mice were treated with saline
or desipramine (7.5 mg per kg, i.p.) 45 min before training and were
tested for the same task. ANOVA indicated a signi®cant interaction
between genotype and treatment for ®nding latency [F (1, 39) = 12.045,
p < 0.005] and for drinking latency [F (1, 39) = 10.397, p < 0.005].
Signi®cant differences according to Newman-Keuls test: **p < 0.01 vs
saline-treated wild-type mice; and ²²p < 0.01 vs saline-treated mutant
mice.
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moderate reduction (73%±80%) relative to the wild-type value.
The spontaneous norepinephrine release level in the frontal cortex
determined by the microdialysis procedure was indistinguishable
between the wild-type and mutant mice, but the release level
through repetitive high K+ stimulation was evidently reduced in
the mutant mice (56% of the wild-type level).
To ®nd behavioral changes derived from reduced norepi-
nephrine biosynthesis, latent learning performance was initially
tested with the water-®nding paradigm, because the perform-
ance is known to be dependent on norepinephrinergic activity
(Ichihara et al, 1993). Latent learning is the phenomenon that
animals learn a maze at a faster rate if they have been
preexposed to the environment (Mackintosh, 1975). In the
water-®nding test, a nonwater-deprived animal is placed in an
environment containing a water tube during a training phase.
Then the animal is water-deprived for 1 d and placed back into
the same environment for the test of the learning performance.
When the wild-type mice were preexposed to the test
apparatus, the latencies for the ®nding and drinking perform-
ances became signi®cantly shorter than those in the nontrained
wild-type mice (Fig 3A); however, the TH mutant mice did
not show a shortening of the ®nding and drinking latencies
despite the training (Fig 3A). This learning de®cit was
recovered by treating mice before the training phase with
desipramine, which stimulates the synaptic activity by inhibiting
norepinephrine reuptake (Fig 3B). The recovery experiments
Figure 4. Impairment of conditioned learning in the TH mutant mice. (A) Active avoidance paradigm. The wild-type and mutant mice were
tested with the shuttle box paradigm. Mice were treated i.p. with saline or desipramine (7.5 mg per kg) every day 45 min before the trial. Percentage
of successful avoidances in 10 trials per day is plotted. Values indicate mean 6 SEM of data. In the saline-injected animals (left panel), according to two-
way ANOVA there were signi®cant main effects between genotypes [F (1, 22) = 18.513, p < 0.001] and among trial days [F (6, 132) = 83.730, p
< 0.001]. The interaction between the two factors was signi®cant [F (6, 132) = 2.531, p < 0.05]. Asterisks show signi®cant differences from the wild-
type mice (*p < 0.05; **p < 0.01, Newman-Keuls test). In the desipramine-treated animals (right panel), the main effect among trial days was signi®cant
[ANOVA, F (6, 120) = 63.776, p < 0.001], the main effect between genotypes was not signi®cant, and there was no interaction between genotype and
trial day. (B) Tone-cued fear conditioning. The wild-type and mutant mice were tested 1 h and 24 h after conditioning for freezing in the presence of
a continuous sound for 1 min. Freezing response was tested in advance in the preconditioning period of 1 min (Pre). Mice were treated i.p. with saline
or desipramine (15 mg per kg) after the conditioning phase. Values indicate mean 6 SEM of data. In the saline-injected animals (left panel) there was a
signi®cant interaction between genotype and trial time [ANOVA, F (2, 40) = 4.94, p < 0.05]. Asterisk shows a signi®cant difference from the wild-type
mice (**p < 0.01, Newman-Keuls test). In the desipramine-injected animals (right panel) there was no interaction between the two factors. (C)
Conditioned taste aversion. Mice were tested 1 d and 2 d after conditioning by measuring sucrose intake for 10 min from one drinking bottle. Sucrose
intake in the preconditioning period (Pre) is shown. Mice were treated i.p. with saline or desipramine (15 mg per kg) after the conditioning phase.
Values indicate mean 6 SEM of data. In the saline-injected animals (left panel) there was a signi®cant interaction between genotype and trial day
[ANOVA, F (2, 22) = 4.15, p < 0.05]. Asterisk shows a signi®cant difference from the wild-type mice (**p < 0.01, Newman-Keuls test). In the
desipramine-treated animals (right panel) there was no interaction between the two factors.
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imply that the latent learning de®cit is attributed predominantly
to the reduced norepinephrine activity in the brain.
Next, the performance of conditioned learning that requires the
amygdala and its linking pathway was studied with three different
behavioral paradigms. In the active avoidance paradigm dependent
on a tone, the mutant mice learned the paradigm more slowly than
the wild-type mice (Fig 4A, left panel). The rate of the successful
response in the mutant mice was lower up to the ®fth trial day, and
the success of avoidance in the ®fth trial was 75%, but the rate
attained normal levels at the sixth and seventh trial days. This mild
impairment of active avoidance was restored by desipramine
treatment (Fig 4A, right panel). To further characterize the de®cit
in conditioned learning performance of the mutant, the tone-cued
fear conditioning was utilized. In this paradigm, the animals learn
an association between a foot shock US and a tone CS, and the
reexposure of a CS induces the freezing behavior to the animals. At
1 h after the conditioning, both wild-type mice and mutant mice
exhibited similar freezing response (Fig 4B, left panel). In contrast,
at 24 h after the conditioning, the wild-type mice sustained the
performance, whereas the freezing response in the mutant mice was
signi®cantly reduced from the value at 1 h after the conditioning. In
the mutant, the acquisition and short-term memory of the
conditioned fear were normal, but the long-term memory was
impaired. This learning de®cit was also restored by desipramine
treatment after the conditioning (Fig 4B, right panel). Another
conditioned learning paradigm, conditioned taste aversion, con-
®rmed a role of norepinephrine in the long-term memory. This
requires an association between a taste CS and visceral malaise-
inducing US. In the conditioning phase, the animals receive a novel
taste (0.5 M sucrose) from a drinking bottle as a CS, followed by an
intraperitoneal injection of lithium chloride as a US. The US
induces a sickness soon after the injection, and thus conditioned
animals show aversive behavior to the taste CS. On day 1 after the
conditioning, both wild-type mice and mutant mice exhibited the
taste aversion to a similar extent (Fig 4C, left panel). On day 2, the
wild-type mice continued to exhibit aversive responses, whereas
the mutant mice took sucrose to almost the same extent as during
the preconditioning period. Post-training desipramine treatment
also restored the learning performance in the mutant mice (Fig 4C,
right panel).
The TH mutant mice displayed the de®cits in three kinds of
associative learning paradigms, including active avoidance, cued
fear conditioning, and conditioned taste aversion. The behavioral
changes in the fear conditioning and conditioned taste aversion
suggest the impairment of the consolidation process for the long-
term memory in the mutant. In the active avoidance, the mutant
mice learned the performance more slowly than the wild-type
animals during the successive training. In this paradigm, the
performance was examined daily. The defect in memory consoli-
dation after daily training may lead to the slow acquisition rate of
learning performance. The memory de®cits in the mutant mice
were completely recovered by the desipramine treatment. These
experiments provide genetic evidence that the central norepi-
nephrine system plays a key role in long-term memory formation of
conditioned learning. This process is highly susceptible to a
reduction in the norepinephrinergic activity.
Which brain regions are involved in the long-term memory of
conditioned learning? Several behavioral studies have indicated that
the associative learning require the amygdala and its linking
pathways (LeDoux et al, 1990; Everitt et al, 1991; Yamamoto et al,
1995). Previous pharmacologic studies have suggested that the
norepinephrine system in the amygdala enhances memory forma-
tion (McGaugh et al, 1996; Quirarte et al, 1997). The impairment
of conditioned learning in the mutant mice may be attributed in
part to dysfunction of the amygdala. In addition, one needs to
consider the role of the cerebral cortex in long-term memory
formation. For instance, the perirhinal cortex is required for
conditioned learning dependent on auditory or visual stimili,
particularly during the post-training phase (Campeau and Davis,
1995; Corodimas and LeDoux, 1995). The insular cortex, which
contains the gustatory cortex, is necessary for the retention of the
taste aversion (Yamamoto et al, 1980; Gallo et al, 1992). The central
norepinephrinergic neurons modulate the excitability of pyramidal
neurons in various areas of the cerebral cortex (Robbins and
Everitt, 1995). Therefore, dysfunction in the cerebral cortex due to
the reduced norepinephrinergic activity may cause the impairment
in long-term memory. To understand the neuronal mechanism
underlying the norepinephrinergic control of long-term memory,
it is of interest to determine alterations in norepinephrine
metabolism and synaptic activity correlated with the behavior in
speci®c brain regions, including amygdala and cortical regions.
CONCLUSION
In this review I described the mutant phenotype of the mice with
impaired catecholamine biosynthesis. Analysis of these mutant mice
has demonstrated an essential role of the two catecholamines in the
physiologic and behavioral functions: dopamine is crucial for motor
control and emotional learning during postnatal development; and
norepinephrine is required for the latent learning and long-term
memory formation of conditioned learning. Knowledge obtained
from mutant animals are useful to elucidate the role of
catecholamine signaling in the CNS functions. Also, it provides
an important basis for understanding the etiology and pathogenesis
of neurologic and neuropsychiatric disorders associated with altered
catecholamine metabolism.
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